In formulating either a positive or negative view of global healthcare businesses, one has to consider the US healthcare system being the largest in the world in terms of both drug and medical device sales.
It spends far more as a percentage of GDP than any other developed nation at over 16%, and accounts for roughly 40% (or $425bn) of global pharmaceuticals sales and about 44% (or $190bn) of global medical...
'Elaborate breach of trust'
Latest news and analysis
Industry Voice: Lyxor ETF's guide to investing in US Equities
Further statement tomorrow
‘Still work to do' on Cofunds